Our Capabilities
Integrated Biotechnology Development
From Discovery to Translation and Scale
Imperion Biotech integrates discovery, molecular and cellular research, product development, preclinical validation, precision medicine and bioprocess capabilities within one connected development platform.
Discovery & Translational Biology
We develop biologically relevant experimental systems that connect fundamental mechanisms with translational research and downstream development.
Why Imperion
Rather than applying standard assays to every project, we structure cellular workflows around disease biology, product claims, mechanism of action and downstream development needs.
What We Can Do
- 2D Cell Culture Systems
- 3D & Organoid Models
- Co-Culture & Microenvironment Models
- Disease-Oriented Experimental Models
- CRISPR, siRNA & Gene Modulation
- Extracellular Vesicle & Exosome Research
Key Capabilities
- Project-specific model selection
- Mechanism-focused experimental design
- Viability, proliferation & cytotoxicity readouts
- Treatment- and dose-response studies
- Disease-relevant experimental setup
- Translational interpretation of biological data
Molecular & Biomarker Intelligence
We transform biological responses into measurable molecular insight through integrated gene, protein, biomarker and cellular profiling strategies.
Why Imperion
We help define which molecular markers matter, how they should be measured and how the results can support development decisions, product strategy or translational positioning.
What We Can Do
- Gene Expression & qPCR Profiling
- miRNA & RNA-Based Readouts
- Protein & ELISA Analysis
- Histology, IHC & Digital Quantification
- Flow Cytometry & Cellular Phenotyping
- Biomarker Discovery & Validation
Key Capabilities
- Biomarker panel design
- Pathway-oriented marker selection
- Gene and protein-level validation logic
- Immune and cellular phenotype planning
- Tissue and image-based quantification strategy
- Decision-oriented data interpretation
Product & Formulation Development
We connect formulation and material concepts with biological evidence to support product development, optimization and claim-relevant validation.
Why Imperion
We pair each formulation or material concept with suitable biological models, helping teams understand performance, compatibility, mechanism and claim-supportive potential.
What We Can Do
- Formulation Screening & Optimization
- Functional Product Validation
- Cytotoxicity & Biocompatibility Screening
- Biomaterials & 3D Systems
- Delivery & Nanoparticle Concepts
- Custom Assay Development
Key Capabilities
- Product-specific assay development
- Biological performance evaluation
- Biomaterial–cell interaction studies
- Skin, wound-healing & regeneration models
- Comparative formulation testing
- Claim-supportive experimental design
Biologics, Peptides & Biotechnology Raw Materials
We develop biotechnology-derived products and raw materials through integrated peptide, recombinant, antibody and bioprocess development strategies.
Why Imperion
We understand both scientific feasibility and industry translation. Our approach connects peptide, recombinant and antibody concepts with production logic, analytical characterization and scale-up readiness.
What We Can Do
- Peptide Development
- Recombinant Protein Development
- Antibody Development
- Upstream & Downstream Process Design
- Purification & Analytical Characterization
- Assay-to-Process Translation
Key Capabilities
- Process development strategy
- Expression & purification workflows
- Peptide synthesis development
- Analytical characterization planning
- Scale-up readiness assessment
- Manufacturing-oriented development
Preclinical Development & Validation
We design integrated preclinical programs using in vitro, ex vivo and in vivo models to evaluate biological efficacy, safety and translational relevance.
Why Imperion
We connect in vitro findings with preclinical logic, helping define the right model, treatment schedule, endpoint strategy and tissue-level readouts before moving toward clinical or product development.
What We Can Do
- In Vitro Efficacy Studies
- Ex Vivo Experimental Models
- In Vivo Disease Models
- Oncology & Metabolic Models
- Safety & Tolerability Assessment
- Histology & Translational Endpoints
Key Capabilities
- Model & endpoint selection
- Dose and treatment schedule design
- Biomarker integration
- Functional & behavioral readouts
- Tissue collection & histopathology
- Translational data-package strategy
Precision Oncology & Clinical Translation
We integrate patient-derived models, molecular profiling and functional evidence to support precision oncology and clinically oriented biotechnology development.
Why Imperion
We connect patient-derived evidence with molecular and functional readouts, helping align translational oncology studies with clinical questions, patient stratification and industry–clinic development goals.
What We Can Do
- Patient-Derived Tumor Models
- Functional Drug-Response Profiling
- Translational Biomarker Programs
- Clinical Cohort Research
- Molecular & Functional Data Integration
- Clinical Development Strategy
Key Capabilities
- Functional precision medicine workflows
- Patient-derived model development
- Translational oncology study design
- Biomarker-driven patient stratification
- Clinical sample-based research
- Industry–clinic translational programs
Scientific Development Support
Supporting capabilities that accompany our development programs.
- Grant Strategy
- Protocol Development
- Scientific Writing
- Manuscript Development
- Research Documentation
Why Imperion
The Imperion Advantage
Integrated Development
Discovery, validation, translation and scale-up are connected within one development logic.
Project-Specific Strategy
Every program is designed around its biological question, development stage and intended outcome.
Translational Depth
We combine molecular, cellular, preclinical, clinical and industry-facing perspectives.
Collaborative Execution
We work directly with biotechnology, pharmaceutical, clinical and academic partners.
Decision-Ready Evidence
Our programs are structured to generate interpretable evidence that supports the next development decision.
Ready to Advance
Your Project?
Tell us where your program stands and where it needs to go. We'll help define the most effective development pathway.